🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 64131A105
- Market Cap
- Small Cap
- IPO
- 6/28/2018 · $17.00/share
Business: Neuronetics, Inc. is a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood.
Company Contact
- CEO
-
Keith J. Sullivan
- CFO
- Steve Furlong
- Headquarters
- 3222 Phoenixville Pike, Malvern, PA 19355
- Phone
- 610-640-4202
- Investor Relations
- Mark Klausner, Westwicke Partners · 443-213-0501 · IR@neuronetics.com